Oesophageal cancer.
Yang H, Wang F, Hallemeier CL, Lerut T, Fu J.
Lancet. 2024 Nov 16;404(10466):1991-2005. doi: 10.1016/S0140-6736(24)02226-8.
Tumor implantation following percutaneous endoscopic gastrostomy insertion for head and neck and oesophageal cancer: Review of the literature.
Rowell NP.
Head Neck. 2019 Jun;41(6):2007-2015. doi: 10.1002/hed.25652. Epub 2019 Jan 25.
Improving individualised therapies in localised gastro-oesophageal adenocarcinoma.
Svrcek M, Voron T, André T, Smyth EC, de la Fouchardière C.
Lancet Oncol. 2024 Sep;25(9):e452-e463. doi: 10.1016/S1470-2045(24)00180-3.
Targeting IGF1R signaling enhances the sensitivity of cisplatin by inhibiting proline and arginine metabolism in oesophageal squamous cell carcinoma under hypoxia.
Fang K, Sun M, Leng Z, Chu Y, Zhao Z, Li Z, Zhang Y, Xu A, Zhang Z, Zhang L, Chen T, Xu M.
J Exp Clin Cancer Res. 2023 Mar 28;42(1):73. doi: 10.1186/s13046-023-02623-2.
Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study.
Miyoshi J, Mannucci A, Scarpa M, Gao F, Toden S, Whitsett T, Inge LJ, Bremner RM, Takayama T, Cheng Y, Bottiglieri T, Nagtegaal ID, Shrubsole MJ, Zaidi AH, Wang X, Coleman HG, Anderson LA, Meltzer SJ, Goel A; FINBAR-EMERALD collaborative group.
Gut. 2025 Jan 17;74(2):169-181. doi: 10.1136/gutjnl-2024-333364.
International Tumor Budding Consensus Conference criteria determine the prognosis of oesophageal adenocarcinoma with poor response to neoadjuvant treatment.
Lohneis P, Rohmann J, Gebauer F, Hieggelke L, Bruns C, Schröder W, Büttner R, Löser H, Quaas A.
Pathol Res Pract. 2022 Apr;232:153844. doi: 10.1016/j.prp.2022.153844. Epub 2022 Mar 15.
Palliation of malignant dysphagia from oesophageal cancer. Rotterdam Oesophageal Tumor Study Group.
Siersema PD, Dees J, van Blankenstein M.
Scand J Gastroenterol Suppl. 1998;225:75-84. doi: 10.1080/003655298750027272.
SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
Wang C, Li Y, Wang L, Han Y, Gao X, Li T, Liu M, Dai L, Du R.
Br J Cancer. 2024 May;130(11):1770-1782. doi: 10.1038/s41416-024-02683-x. Epub 2024 Apr 10.
Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma.
Gao W, Liu S, Wu Y, Wei W, Yang Q, Li W, Chen H, Luo A, Wang Y, Liu Z.
EBioMedicine. 2024 Jul;105:105177. doi: 10.1016/j.ebiom.2024.105177. Epub 2024 Jun 25.
Neoadjuvant treatment in oesophageal cancer: the needs for future trials. The Rotterdam Esophageal Tumor Study Group.
Kok TC, Tilanus HW.
Eur J Surg Oncol. 1996 Aug;22(4):323-5. doi: 10.1016/s0748-7983(96)90066-9.
